Evidence for beneficial effect of recombinant interleukin-2 in HIV-associated B lymphoma

Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

European journal of haematology·2026

Multilevel surveillance of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae from companion animals: Evidence from a Veterinary University Hospital before and after EU Regulation 2022/1255.

Veterinary microbiology·2026

Implementation considerations for integrated face and respiratory protection: a qualitative study.

The Journal of hospital infection·2025

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.

European journal of haematology·2024

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

Frontiers in pharmacology·2023

In the search for appropriateness in the cure of vaginitis: a model of anti-fungal stewardship?

European review for medical and pharmacological sciences·2022

Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

AIDS (London, England)·2026

Cancer incidence and risk factors among people with HIV in REPRIEVE.

AIDS (London, England)·2026

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

AIDS (London, England)·2026

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

AIDS (London, England)·2026

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

AIDS (London, England)·2026

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

AIDS (London, England)·2026

Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

Journal of visualized experiments : JoVE·2026

Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

Regenerative therapy·2026

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

Regenerative therapy·2026

Beyond immune suppression: regenerative programs in regulatory T cells.

Cell insight·2026

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

BMJ neurology open·2026

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Antibody therapeutics·2026

Related Experiment Videos

Evidence for beneficial effect of recombinant interleukin-2 in HIV-associated B lymphoma

Related Concept Videos

Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.

Multilevel surveillance of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae from companion animals: Evidence from a Veterinary University Hospital before and after EU Regulation 2022/1255.

Implementation considerations for integrated face and respiratory protection: a qualitative study.

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

In the search for appropriateness in the cure of vaginitis: a model of anti-fungal stewardship?

Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

Cancer incidence and risk factors among people with HIV in REPRIEVE.

Effects of semaglutide on subclinical cardiovascular health in people with HIV.

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

Beyond immune suppression: regenerative programs in regulatory T cells.

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Related Experiment Videos

Evidence for beneficial effect of recombinant interleukin-2 in HIV-associated B lymphoma

Related Concept Videos

Related Articles